Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -49.13 |
| peg ratio | -0.04 |
| price to book ratio | 221.00 |
| price to sales ratio | 7.42 |
| enterprise value multiple | -32.20 |
| price fair value | 221.00 |
profitability ratios | |
|---|---|
| gross profit margin | 93.46% |
| operating profit margin | -22.99% |
| pretax profit margin | -29.24% |
| net profit margin | -30.0% |
| return on assets | -27.49% |
| return on equity | -210.18% |
| return on capital employed | -27.95% |
liquidity ratio | |
|---|---|
| current ratio | 2.69 |
| quick ratio | 2.59 |
| cash ratio | 1.86 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 140.04 |
| operating cycle | 190.78 |
| days of payables outstanding | 526.56 |
| cash conversion cycle | -335.78 |
| receivables turnover | 7.19 |
| payables turnover | 0.69 |
| inventory turnover | 2.61 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.56 |
| debt equity ratio | 9.20 |
| long term debt to capitalization | 0.90 |
| total debt to capitalization | 0.90 |
| interest coverage | -3.20 |
| cash flow to debt ratio | -0.25 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.80 |
| cash per share | 14.85 |
| operating cash flow per share | -4.56 |
| free cash flow operating cash flow ratio | 1.05 |
| cash flow coverage ratios | -0.25 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -19.15 |
Frequently Asked Questions
Calliditas Therapeutics AB (publ) (CALT) published its most recent earnings results on 13-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Calliditas Therapeutics AB (publ) (NASDAQ:CALT)'s trailing twelve months ROE is -210.18%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Calliditas Therapeutics AB (publ) (CALT) currently has a ROA of -27.49%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
CALT reported a profit margin of -30.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.69 in the most recent quarter. The quick ratio stood at 2.59, with a Debt/Eq ratio of 9.20.